... to in the content or advertisements. Breast cancer Clusterin Methylation Research Article Tumor Biol 2009;30:286 291 DOI: 10.1159/000259912 Received: April 29, 2009 Accepted after revision: September 2, 2009 Published online: November 20, 2009 Regulation of Clusterin Expression in Human Cancer via DNA...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Atypical hyperplasia Breast cancer Carcinogenesis Ductal carcinomain situ Matrix...

...P. Doolan; M. Clynes; S. Kennedy; J.P. Mehta; S. Germano; C. Ehrhardt; J. Crown; L. O’Driscoll Background/Aims: A panel of prognostic and predictive biomarkers would contribute to personalised treatment of breast cancer patients. However, many such biomarkers have yet to be identified and evaluated...

... be expressed in breast cancer. The aim of this study was to examine breast cancer outcome in relation to expression of ER-β. Methods: In this investigation, we measured the expression of ER-α protein and ER-β mRNA in 121 extracts of invasive breast cancer. Association of expression with clinical outcome...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Membrane potentials Depolarization K + channels MCF10A cells MCF 7 cells Micropipettes Original Paper Tumor Biol 1994;15:82-89 Andrew A. Marinoa > b Ilko G. Hieva...

... to in the content or advertisements. Invasion Metastasis Breast cancer Extracellular matrix Elastin Collagen Review Tumor Biol 1993;14:137-143 Donald F. Parsons Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany, N.Y., USA Tumor Cell Interactions with Stromal...

... affected by different types of neoplasms. In this study we have evaluated osteoblastic and osteoclastic markers in 18 patients with bone metastases from breast cancer at diagnosis and for 1 year of follow-up during treatment with the aromatase inhibitor formestane. Osteoblastic markers include the carboxy...

... directly with cellular differentiation and inversely with proliferative activity in normal epithelium and in several human tumor systems. In order to determine the role of p68 in human breast cancer, we utilized immunohistochemistry and mapped the expression of p68 in tissue from 200 breast biopsy...

...H. Inaji; H. Koyama; K. Motomura; S. Noguchi; Y. Mori; Y. Kimura; K. Sugano; H. Ohkura The levels of c-erbB-2 oncoprotein (ErbB-2 protein) in nipple discharge were evaluated together with those of carcinoembryonic antigen (CEA) in 9 patients with breast cancer, 2 patients with borderline lesions, 8...

...B. Klein; I. Levin; B. Kfir; M. Mishaeli; J. Shapira; T. Klein The serum levels of soluble interleukin-2 (sIL-2), sIL-2 receptors (sIL·2R), β 2 -microglobulin (β 2 M) and soluble intercellular adhesion molecule-1 (sICAM-1) were measured by the ELISA technique in 129 breast cancer patients and 40...

...M. Busetto; L. Vianello; R. Franceschi; M. Bolzan The role of CA 15-3 in breast cancer has been widely studied by several authors. This study was designed to describe the predictivity of CA 15-3 determinations for the metastasis or second primary tumor in patients subjected to follow-up for breast...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Progesterone receptor Breast cancer Cell cycle Immunofluorescence Ki...

...Paul S. Frenette; Michael P. Thirlwell; Marc Trudeau; D.M.P. Thomson; Lawrence Joseph; Joseph S. Shuster In the past decade, considerable interest has arisen for defining the role of various tumor markers in the diagnosis of cancer. This cross-sectional study evaluates four breast cancer markers...

... of the present study was to evaluate tumor marker variability in the follow-up of patients resected for breast cancer. So far, we have carried out 2,085 CEA and 2,550 CA 15-3 determinations in 435 patients. The total variability of both CEA and CA 15-3 was widely scattered among different subjects (CEA...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Electrical Potential Cancer diagnosis K + channels Original Paper Tumor Biol 1994;15:147-152 Andrew...

...M.D. Ortega; M.L. Maestro; G. Encabo; C. Varón; M.T. Allende; I. Martinez; G. Palacios CA 15-3 is the most widely used tumour marker in the follow-up of patients with breast cancer. Its postoperative blood level is closely related to the response to the treatment applied and to the evolution...

...Danila Coradini; Anna Biffi; Cinzia Pellizzaro; Ester Pirronello; Giovanni Di Fronzo To improve the effectiveness of 4-hydroxyphenylretinamide (4-HPR), an analogue of retinoic acid used in chemoprevention and treatment of breast cancer, we investigated the effect of concomitant administration of 4...

..., instructions or products referred to in the content or advertisements. pS2 Labeling index Breast cancer Hormone responsiveness Prognosis Original Paper Tumor Biol 1993;14:30-37 M. Corréalea A. Paradisob I. Abbatea A. Mangiab C.D. Dragone* T. Tedonea R. Filoticoc F. Schittullid M. De Lenab...

... cancer. Using the three assays, breast cancer mucin enzyme immunoassay (BCM-EIA) carcinoma-associated mucin antigen (CAM) 26 and CAM 29, both singly and in combination, we were unable to establish meaningful cut-offs to differentiate between patients with or without breast cancer. The sensitivity...

...S.Y. Wong; A. Purdie; H.F. Sewell; L. Wilkinson; B. Angus; B. Westley; C.H.W. Horne A new mouse anti-oestrogen receptor (ER) monoclonal antibody, ER-P31, has been developed. Comparisons of immunohistochemical detection of ER in human breast cancers using ER-P31 with anti-ER from ER...